Second malignant neoplasms and cardiovascular disease following radiotherapy.
Ontology highlight
ABSTRACT: Second malignant neoplasms (SMNs) and cardiovascular disease (CVD) are among the most serious and life-threatening late adverse effects experienced by the growing number of cancer survivors worldwide and are due in part to radiotherapy. The National Council on Radiation Protection and Measurements (NCRP) convened an expert scientific committee to critically and comprehensively review associations between radiotherapy and SMNs and CVD, taking into account radiobiology; genomics; treatment (ie, radiotherapy with or without chemotherapy and other therapies); type of radiation; and quantitative considerations (ie, dose-response relationships). Major conclusions of the NCRP include: 1) the relevance of older technologies for current risk assessment when organ-specific absorbed dose and the appr
SUBMITTER: Travis LB
PROVIDER: S-EPMC3295744 | biostudies-literature | 2012 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA